Gangwal Chemicals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 3.70 Cr
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 93.75 Cr
- Revenue Growth 2.86%
- Profit Growth 92.25%
- Ebitda 53.87%
- Net Worth 84.59%
- Total Assets 9.76%
About Gangwal Chemicals
Gangwal Chemicals Pvt Ltd (GCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 November 1987 and has a history of 37 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 3.70 Cr.
The company has closed loans amounting to ₹93.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gangwal Chemicals Pvt Ltd India is Sanjeevani Bagul as COMPANY SECRETARY. Mitesh Jain and Geeta Varma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110MH1987PTC045235
- Company No.
045235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Gangwal Chemicals Pvt Ltd offer?
Gangwal Chemicals Pvt Ltd offers a wide range of products and services, including Pharmaceutical Excipients, Beta Cyclodextrin Powder, Industrial Storage Rack, Multi Tier Rack, Anti Infective Drugs & Medicines, Malaria Medicine, Flavours & Aromatics, Artificial Sweetener, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Gangwal Chemicals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjeevani Bagul ![]() | Company Secretary | 06-Dec-2019 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mitesh Jain | Additional Director | 25-Jan-2024 | Current |
Geeta Varma ![]() | Additional Director | 25-Jan-2024 | Current |
Financial Performance of Gangwal Chemicals.
Gangwal Chemicals Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 2.86% increase. The company also saw a substantial improvement in profitability, with a 92.25% increase in profit. The company's net worth Soared by an impressive increase of 84.59%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gangwal Chemicals?
In 2021, Gangwal Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹93.75 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 53.00 Cr
- Others : 15.80 Cr
- Dbs Bank Ltd : 15.00 Cr
- Citibank N. A. : 4.00 Cr
- 3I Infotech Trusteeship Services Limited : 3.52 Cr
- Others : 2.43 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
02 Jul 2019 | Dbs Bank Ltd | ₹15.00 Cr | Satisfied |
20 Mar 2019 | Citi Bank N.A. | ₹29.00 Cr | Satisfied |
28 Dec 2018 | Others | ₹11.80 Cr | Satisfied |
05 Feb 2018 | Others | ₹4.00 Cr | Satisfied |
13 Mar 2009 | Icici Bank Limited | ₹1.56 Cr | Satisfied |
How Many Employees Work at Gangwal Chemicals?
Gangwal Chemicals has a workforce of 33 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gangwal Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gangwal Chemicals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.